Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Regenerex Pharma (RGPX) Cash from Discontinued Operations (2021 - 2022)

Regenerex Pharma (RGPX) reported Cash from Discontinued Operations of 3248.0 for Q1 2022, up 418.12% on a QoQ basis from 1021.0 in Q4 2021.

Regenerex Pharma (RGPX) has 2 years of Cash from Discontinued Operations data on file, last reported at 3248.0 in Q1 2022.

  • Quarterly Cash from Discontinued Operations changed N/A year-over-year to 3248.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was 5510.0 (changed N/A YoY) and the FY2022 annual result came in at 5510.0, changed N/A from the prior year.
  • Cash from Discontinued Operations improved to 3248.0 in Q1 2022 per RGPX's latest filing, from 1021.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 3248.0 in Q1 2022 and bottomed at 5275.0 in Q2 2021.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 3,248.00
Mar 31, 2022 3,248.00
Dec 31, 2021 -1,021.00
Dec 31, 2021 -1,021.00
Sep 30, 2021 -2,462.00
Sep 30, 2021 -2,462.00
Jun 30, 2021 -5,275.00
Jun 30, 2021 -5,275.00